Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
about
New insights into HIV-1-primary skin disordersHIV I infection of dendritic cells.Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epitheliaPathogenesis of human immunodeficiency virus infectionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsReplication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynuclInhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosidesUltrastructural pathology of human immunodeficiency virus infection.Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins.Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.A rational basis for mucosal vaccination against HIV infection.Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophagesVariation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitroHost defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?Morphological and immunological changes in the skin of autopsied women with AIDS.Attitude of nurses in a burn unit to hiv/aids burn patientsThe enigma of Kaposi's sarcoma: an answer at last?HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.The pathogenetic basis of viral tropismThe spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytesLocalization of SIV in the genital tract of chronically infected female rhesus macaquesInfection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients.Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytesDangerous liaisons at the virological synapse.Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groupsFailure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytesSpatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infectionPrimary stage of feline immunodeficiency virus infection: viral dissemination and cellular targetsAntisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophagesOvine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes.Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants.Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIVMacrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptorIn vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.
P2860
Q21198772-F39BC996-1892-45D4-B9B7-B43574A29F9FQ22241260-B75C9B85-ACE1-4DC9-8A24-09B71958087FQ24541451-074670CF-533A-4600-86F2-36DF32EB80F3Q24634681-1A344FD3-E256-4803-98AA-EFBBB6C5FE5DQ24651506-CF289212-CE81-4EC5-AC9D-9B89CEF48DF8Q28342341-3814A5C8-A9FF-40DA-9EDF-C7090CA017C4Q28359853-8D6DD828-83FE-434F-AFA6-245775D1DFF3Q33209535-E493814B-52BD-41CE-94EA-8BBCE063F9E1Q33246074-1D72EAD3-65B1-4EA6-B239-8992EDBDC364Q33547146-D1400133-73E2-4AC3-95FF-6F7C5612BC9CQ33654203-B3BEB4BB-E35F-494E-A4E6-4F17C42FDC56Q33776167-CEC16AA2-9FB4-4E37-8EA2-35D8878BF77AQ33854355-402CCA44-CCD4-4688-9999-85CDEF3078DDQ34170655-5258E722-F461-4753-B4B3-DB47D6D97E84Q34240496-943693E7-79C4-4BF8-A684-43079CFCEB89Q34246280-DBED265E-DE84-4B38-A49F-6C971315D709Q34254490-1276762A-774A-40F4-88CF-B0573B0FF4A8Q34381159-B3F61A02-CEE9-46E8-BF47-AFF9246151EEQ35279119-193AE949-8A93-4A9C-9BB6-4996912784D2Q35545007-D75B14D4-3861-478F-B6C3-C4D6C01774D3Q35557244-2F50FDE2-6DD1-41D4-9885-B4F2F4BFAAF2Q35596389-39FA64EF-16D1-497C-8BAA-8B26453CA84FQ35763994-0E8ED1AE-6550-43DF-A19D-504512681FF5Q35816763-D162062A-2CFC-4D69-B253-31BA3BCB0160Q35817323-AC621AAF-BF69-4C57-B0C2-4C7DDB778D6AQ35832172-0E159C07-9901-4A22-A8D4-3EBAC2E9928AQ35844197-C43B171E-A099-47DB-B765-34D83ED8AD8AQ35852056-77FDCAAF-3903-4823-9760-AF90C1A96292Q35877219-8F912E1A-548A-47AB-80B0-527E0B115BFAQ35896410-E3D4E726-5231-40B3-9E6A-3196FBAE16D3Q36353945-FAE6454C-733E-4CEA-B8B8-DFCE8215C903Q36354762-620D36EF-556A-4762-9B8C-EE174E18F8F7Q36625926-CFFB1E69-67AE-40DC-9E29-847DF70625A9Q36633454-5AAF6AF2-B506-4B73-BC58-EECD61ECD4F7Q36650619-848358DD-EB44-4471-AE0F-9DD2A78B2FACQ36696943-A347D2C7-E11F-4935-BF8C-3DC20DFBFDFCQ36698525-3EB180D0-CAD8-4C15-B376-96F14DFAC64BQ36706107-E53ECB14-0981-46E7-A691-09B85071D21BQ36783162-0B3A6974-510F-46F5-A5B6-533B1E77D774Q36797895-25C1A2AA-07DB-42D3-840A-D4A2096FAE68
P2860
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@en
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@nl
type
label
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@en
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@nl
prefLabel
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@en
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@nl
P2093
P1476
Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
@en
P2093
diMarzo Veronese F
P2888
P304
P356
10.1111/1523-1747.EP12525402
P407
P577
1987-02-01T00:00:00Z
P5875
P6179
1007411607